Arnold LM, Williams DA, Hudson JI, Martin SA, Clauw DJ, Crofford LJ, Wang F, Emir B, Lai C, Zablocki R, Mease PJ. Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum. 2012 Mar 1;64(3):885-94.
Smith VK, Evans MF, Banzhaf HS, Poulos C. Can weak substitution be rehabilitated? Environ Resour Econ (Dordr). 2010 Feb 1;45(2):203-21.
Bongartz T, Warren FC, Mines D, Matteson EL, Abrams KR, Sutton AJ. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. Presented at the 2008 Annual Meeting of the American College of Rheumatology; October 2008. San Francisco, CA. [abstract] Arthritis Rheum. 2008 Sep; 58(9 Suppl):S782.
Keeenan AM, McKenna SP, Doward LC, Conaghan PC, Emery P, Tennant A. OAQoL: the development and validation of a needs-based quality of life instrument for osteoarthritis. Arthritis Rheum. 2008 Jun 1;59(6):841-8.
Mansfield CA. Despairing over disparities: an empirical analysis of the relationship between willingness-to-pay and willingness-to-accept. Environ Resour Econ (Dordr). 1999;13(2):219-34.
Palka P, Lange A, Wright RA, Starkey IR, Fleming AD, Bouki KP, Sutherland GR, Shaw TRD, Fox KAA. Myocardial velocity gradient measured throughout the cardiac cycle in dilated cardiomyopathy hearts — a potential new parameter of systolic and diastolic myocardial function by Doppler myocardial imaging. European journal of ultrasound. 1997 Jun 1;5(3):141-54. doi: 10.1016/S0929-8266(97)00014-1
Hoskins PR, Fleming A, Stonebridge PA, Allan PL, Cameron D. Scan-plane vector maps and secondary flow motions in arteries. European journal of ultrasound. 1994 Apr 1;1(2):159-69.